Chad Patterson - 09 May 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 May 2022, 16:11:43 UTC
Prior SEC filing
13 Apr 2022
Next SEC filing
27 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Jereme Sylvain For: Chad M Patterson

Key filing fact

Chad Patterson filed Form 4 for DEXCOM INC (DXCM) on 10 May 2022.

Key facts

  • This page summarizes Chad Patterson's Form 4 filing for DEXCOM INC (DXCM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 10 May 2022, 16:11.

Change

  • Previous filing in this sequence was filed on 13 Apr 2022.
  • Current net transaction value: -$266,332.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DXCM transaction

Common Stock

Sale

Transaction value
$266,332
Shares
-777
Change %
-5.4%
Price
$342.77
Shares after
13,675
Date
09 May 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.

Footnote F2

Included in this number are 13,675 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .